GC
LJPC

Grimes & Company’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Grimes & Company’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25,270
Closed -$102K – 276
2020
Q3 		$102K Buy
25,270
+1,770
+8% +$7.33K 0.01% 241
2020
Q2 		$100K Hold
23,500
– – 0.01% 240
2020
Q1 		$99K Sell
23,500
-1,000
-4% -$6.32K 0.01% 220
2019
Q4 		$96K Buy
+24,500
New +$145K 0.01% 260

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Grimes & Company's LJPC Position: Q4 2020 in Review

Grimes & Company sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2020, closing a stake of 25,270 shares — an estimated $102K sold.

Grimes & Company first reported a position in LJPC in Q4 2019 and held it in 4 quarters. The position peaked at $102K in Q3 2020. 65 funds tracked by Wall St. Rank hold LJPC as of Q4 2020.

  • Grimes & Company reported no remaining La Jolla Pharmaceutical Company position as of Q4 2020 after selling out during the quarter.
  • Grimes & Company sold 25,270 La Jolla Pharmaceutical Company shares in Q4 2020, an estimated $102K.
  • Grimes & Company first reported a position in La Jolla Pharmaceutical Company in Q4 2019 and held it in 4 quarters.
  • Grimes & Company's La Jolla Pharmaceutical Company position peaked at $102K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2020.

Based on Grimes & Company's 13F filing for Q4 2020, filed 2 Feb 2021.